Karolinska University Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2016

  1. Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia

    European Heart Journal, Supplement, Vol. 18, pp. C2-C12

2015

  1. A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy

    Atherosclerosis Supplements, Vol. 19, pp. 1-12

2007

  1. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Full text

    Diabetes, Stoffwechsel und Herz, Vol. 16, Núm. 7